Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2

Authors: Chang, K., Willis, J.A., Reumers, J., Taggart, M.W., San Lucas, F.A., Thirumurthi, S., Kanth, P., Delker, D.A., Hagedorn, C.H., Lynch, P.M., Ellis, L.M., Hawk, E.T., Scheet, P.A., Kopetz, S., Arts, J., Guinney, J., Dienstmann, R. ^*, Vilar, E. ^*

Source: In Annals of Oncology October 2018 29(10):2061-2067

35P Enhancing efficacy of the MEK inhibitor trametinib in KRAS-mutated colorectal cancer cells

Authors: Ellis, L.M., Ghosh, S., Fan, F., Bhattacharya, R., Powell, R., Park, Y.S., Stephan, C.

Source: In ESMO Open October 2023 8(1) Supplement 5

American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes

Authors: Ellis, L.M., Bernstein, D.S., Voest, E.E.

Source: JOURNAL OF CLINICAL ONCOLOGY. 32(12):1277-1280

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN353399769&indx=1&recIds=ETOCRN353399769

Negotiating Identity Development Among Undocumented Immigrant College Students: A Grounded Theory Study

Authors: Ellis, L.M., Chen, E.C.

Source: JOURNAL OF COUNSELING PSYCHOLOGY. 60(2):251-264

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN331735435&indx=1&recIds=ETOCRN331735435

Promising Future Biomarkers for Colorectal Cancer
American Society of Clinical Oncology

Authors: Ellis, L.M.

Source: AMERICAN SOCIETY OF CLINICAL ONCOLOGY EDUCATIONAL BOOK. 45:212-214

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN077819226&indx=1&recIds=ETOCCN077819226

Targeting Tumor Angiogenesis
Targeting Different Pathways to Prevent Tumor Cell Development

Authors: Gaur, P., Bose, D., Samuel, S., Ellis, L.M.

Source: SEMINARS IN ONCOLOGY. 36(2):S12-S19

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN251340429&indx=1&recIds=ETOCRN251340429

Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress

Authors: Kopetz, S., Lesslie, D.P., Dallas, N.A., Park, S.I., Johnson, M., Parikh, N.U., Kim, M.P., Abbruzzese, J.L., Ellis, L.M., Chandra, J.

Source: CANCER RESEARCH. 69(9):3842-3849

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN250583770&indx=1&recIds=ETOCRN250583770

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

Authors: Dallas, N.A., Xia, L., Fan, F., Gray, M.J., Gaur, P., van Buren, G., Samuel, S., Kim, M.P., Lim, S.J., Ellis, L.M.

Source: CANCER RESEARCH. 69(5):1951-1957

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN247516116&indx=1&recIds=ETOCRN247516116

Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy

Authors: Ellis, L.M., Hicklin, D.J.

Source: CLINICAL CANCER RESEARCH. 14(20):6371-6375

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN240291640&indx=1&recIds=ETOCRN240291640

Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases

Authors: Kesmodel, S.B., Ellis, L.M., Lin, E., Chang, G.J., Abdalla, E.K., Kopetz, S., Vauthey, J.-N., Rodriguez-Bigas, M.A., Curley, S.A., Feig, B.W.

Source: JOURNAL OF CLINICAL ONCOLOGY. 26(32):5254-5260

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN240286577&indx=1&recIds=ETOCRN240286577

Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies

Authors: Grothey, A., Ellis, L.M.

Source: CANCER JOURNAL -NEW YORK-. 14(3):170-177

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN231079610&indx=1&recIds=ETOCRN231079610

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Authors: Dallas, N.A., Samuel, S., Xia, L., Fan, F., Gray, M.J., Lim, S.J., Ellis, L.M.

Source: CLINICAL CANCER RESEARCH. 14(7):1931-1937

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN228755721&indx=1&recIds=ETOCRN228755721

Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab

Authors: Prewett, M., Deevi, D.S., Bassi, R., Fan, F., Ellis, L.M., Hicklin, D.J., Tonra, J.R.

Source: CLINICAL CANCER RESEARCH. 13(24):7432-7440

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN222621806&indx=1&recIds=ETOCRN222621806

Management of bevacizumab-associated bowel perforation: a case series and review of the literature

Authors: Badgwell, B.D., Camp, E.R., Feig, B., Wolff, R.A., Eng, C., Ellis, L.M., Cormier, J.N. ^*

Source: In Annals of Oncology March 2008 19(3):577-582

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies - correlates with hepatocellular injury

Authors: Pearson, A.S., Izzo, F., Fleming, R.Y.D., Ellis, L.M., Delrio, P., Roh, M.S., Granchi, J., Curley, S.A.

Source: AMERICAN JOURNAL OF SURGERY. 178(6):592-598

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN073703013&indx=1&recIds=ETOCRN073703013

Raise standards for preclinical cancer research Clinical trials might be based on findings that cannot be replicated

Authors: Begley, C.G., Ellis, L.M.

Source: NATURE -LONDON-. 484(7391):531-533

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN309683442&indx=1&recIds=ETOCRN309683442

Bevacizumab Beyond Progression: Does This Make Sense?

Authors: Ellis, L.M., Haller, D.G.

Source: JOURNAL OF CLINICAL ONCOLOGY. 26(33):5313-5315

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN241014276&indx=1&recIds=ETOCRN241014276

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

Authors: Jung, Y.D., Mansfield, P.F., Akagi, M., Takeda, A., Liu, W., Bucana, C.D., Hicklin, D.J., Ellis, L.M.

Source: In European Journal of Cancer May 2002 38(8):1133-1140

1537P - Medical-aid-in-dying use in the US Pacific Northwest

Authors: Blanke, C.D., Leblanc, M., Hershman, D., Meyskens, F., Taylor, L., Ellis, L.M.

Source: In Annals of Oncology October 2018 29 Supplement 8

Cancer: The nuances of therapy

Authors: Ellis, L.M., Reardon, D.A.

Source: NATURE -LONDON-. 458(7236):290-291

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN247158118&indx=1&recIds=ETOCRN247158118